Site-directed mutagenesis can define the effects of altering one or mo
re amino acids within a protein, but this technique may lack sensitivi
ty when used to characterize proteins which differ conformationally or
posttranslationally at multiple sites. A novel alternative approach i
nvolves the direct characterization of wild-type protein isoforms iden
tified by site-specific immunodetection. To this end we have developed
antibodies which recognize ErbB2 subsets characterized by adjacent ty
rosine phosphorylation events (Y-1222 and Y-1248) in the C-terminal ta
il of the oncoprotein. Here we use these phosphoantibodies to demonstr
ate the existence of tyrosine-phosphorylated ErbB2 subsets which diffe
r in their patterns of heterooligomer formation, in vitro autophosphor
ylation, and recruitment of SH2-containing substrates. Furthermore, Y-
1222 and/or Y-1248 phosphoantibody immunoreactivity is readily detecta
ble in ErbB2-overexpressing human breast tumors, in which context thes
e phosphorylation events exhibit significant discordance. These data c
onfirm the value of site-specific immunodetection as a strategy for ch
aracterizing phosphoprotein function in vitro and in vivo and suggest
that multisite phosphotyping of human tumors may contribute novel clin
icopathologic insights into the significance of the ErbB2 overexpressi
on phenotype. (C) 1998 Academic Press.